PIM
AERI

Provident Investment Management’s Aerie Pharmaceuticals AERI Stock Holding History

Provident Investment Management’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-371,174
Closed -$7.13M – 56
2019
Q3 		$7.13M Sell
371,174
-32,144
-8% -$736K 1.07% 21
2019
Q2 		$11.9M Buy
403,318
+8,298
+2% +$320K 1.77% 22
2019
Q1 		$18.8M Buy
395,020
+127,953
+48% +$5.63M 3.08% 18
2018
Q4 		$9.64M Buy
267,067
+5,174
+2% +$243K 1.72% 22
2018
Q3 		$16.1M Buy
+261,893
New +$16.8M 2.29% 18

Other funds holding AERI

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Provident Investment Management's AERI Position: Q4 2019 in Review

Provident Investment Management sold out of Aerie Pharmaceuticals (AERI) in Q4 2019, closing a stake of 371,174 shares — an estimated $7.13M sold.

Provident Investment Management first reported a position in AERI in Q3 2018 and held it in 5 quarters. The position peaked at $18.8M in Q1 2019. 167 funds tracked by Wall St. Rank hold AERI as of Q4 2019.

  • Provident Investment Management reported no remaining Aerie Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Provident Investment Management sold 371,174 Aerie Pharmaceuticals shares in Q4 2019, an estimated $7.13M.
  • Provident Investment Management first reported a position in Aerie Pharmaceuticals in Q3 2018 and held it in 5 quarters.
  • Provident Investment Management's Aerie Pharmaceuticals position peaked at $18.8M in Q1 2019.
  • 167 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2019.

Based on Provident Investment Management's 13F filing for Q4 2019, filed 10 Feb 2020.